Results 281 to 290 of about 9,788,907 (408)

Modulation of class-II antigen expression in human thyroid epithelial cell cultures [PDF]

, 1987
Arnholdt, H., Grammerstorf, S., Gutekunst, R., Scriba, Peter Christian, Wenzel, B. E.   +4 more
core   +1 more source

First‐in‐Human Phase 1 Study to Evaluate the Clinical Pharmacology Properties of RBN‐3143, a Novel Inhibitor of Mono‐Adenosine Diphosphate Ribosyltransferase‐PARP14

Clinical Pharmacology in Drug Development, EarlyView.
Abstract RBN‐3143 is an inhibitor of PARP14 in development for inflammatory diseases. Multiple assessments were conducted to evaluate the clinical pharmacology properties of RBN‐3134. A randomized, double‐blind, placebo‐controlled study assigned healthy volunteers (HVs) to single ascending doses (SADs) (25‐1000 mg) or multiple ascending doses (MADs ...
Thomas M. Polasek, Alexandra Cole, Viviana Bozón, Erika Manyak, Jonathan Novak, Barbara Yang, Briohny A. Johnston, Sudha Parasuraman, Kushal J. Paneliya, Virna Schuck   +9 more
wiley   +1 more source

Primary Hodgkinʼs Disease of the Thyroid

, 1963
T. W. Roberts, Rudolph G. Howard
openalex   +2 more sources

Recent advances in gut microbiota and thyroid disease: pathogenesis and therapeutics in autoimmune, neoplastic, and nodular conditions. [PDF]

Front Cell Infect Microbiol
Fang L, Ning J.
europepmc   +1 more source

Exploring the Association Between Intra‐Patient Variability in Trough Concentration of Pazopanib and Clinical Outcomes in Renal Cell Carcinoma and Soft Tissue Sarcoma Patients

Clinical Pharmacology &Therapeutics, EarlyView.
Pazopanib is an oral tyrosine kinase inhibitor used in patients with either metastatic renal cell carcinoma or soft tissue sarcoma. Pazopanib has a high interindividual variability in pharmacokinetics and pharmacodynamics and a well‐established exposure–response relationship. Therefore, therapeutic drug monitoring is recommended to improve the efficacy–
Amy Rieborn, Eline L. Giraud, Teun van Gelder, Hans Gelderblom, Nielka P. van Erp, Tom van der Hulle, Dirk Jan A. R. Moes   +6 more
wiley   +1 more source

Should we routinely assess ovarian reserve in girls and young women with autoimmune thyroid disease? [PDF]

Heliyon
Wędrychowicz A, Wojtyś J, Januś D, Furtak A, Stelmach M, Starzyk JB.   +5 more
europepmc   +1 more source

A Genetic Twist: Cytologic Evaluation of Pancreatic Adenocarcinoma and Steatohepatitic Hepatocellular Carcinoma in a Patient With a Rare POLE Mutation

Diagnostic Cytopathology, EarlyView.
ABSTRACT Mutations in the DNA polymerase epsilon (POLE) gene are associated with an increased risk of various malignancies, including colorectal and other gastrointestinal, endometrial, ovarian, breast, and brain cancers. In extremely rare cases, POLE mutations have also been associated with pancreatic and hepatobiliary carcinomas.
Lynn Messersmith, Areeba H. Rizvi, Dina El‐Rayes, Jimmie Stewart III   +3 more
wiley   +1 more source

Perfluorooctanoic Acid Exposure and Thyroid Disease in Community and Worker Cohorts

Epidemiology, 2014
A. Winquist, K. Steenland
semanticscholar   +1 more source

Excessive Iodine Intake During Lactation Is Not Related to the Incidence of Thyroid Disease: A 3-Year Follow-Up Study. [PDF]

Nutrients
Park SJ, Lee DK, Lee HJ.
europepmc   +1 more source

Hyperthyroid heart disease: Diagnostic and therapeutic aspects [PDF]

, 1990
Reinwein, Dankwart, Scriba, P. C., Scriba, Peter Christian   +2 more
core   +1 more source